Atmospheric Carbon Dioxide Modifies the Antimicrobial Activity and Oxidative Stress Generated by Ciprofloxacin in Escherichia coli

TL;DR

High levels of atmospheric CO2 reduce the effectiveness of the antibiotic ciprofloxacin in E. coli by altering oxidative stress responses.

Contribution

This study reveals that CO2 modifies the oxidative stress and antimicrobial activity of ciprofloxacin in E. coli.

Findings

CO2 decreases ROS formation but increases RNS formation in E. coli under ciprofloxacin treatment.

Antioxidant defenses like superoxide dismutase and catalase are less active under CO2 conditions.

Ciprofloxacin's antibacterial activity is reduced in the presence of elevated CO2.

Abstract

The accelerated increase in atmospheric CO2 concentration is one of the most pressing problems at present. It is possible that this increase causes slight modifications in intracellular CO2. The aim of this work was to determine whether CO2 at different concentrations can affect the oxidative damage caused by ciprofloxacin (CIP) in Escherichia coli and to evaluate the possible implications of this effect for human health. To identify the effects of CO2 on the action of CIP, reactive oxygen (ROS) and reactive nitrogen (RNS) species were measured at two different CO2 concentrations while monitoring the bacterial antioxidant response. These assays showed that CO2 led to a decrease in ROS formation relative to that under atmospheric conditions (ACs), while it had the opposite effect on RNS formation, which increased relative to that under ACs. Under CO2 conditions, antioxidant defenses were less activated, with superoxide dismutase, catalase, and ferric reducing assay potency decreasing compared to those under ACs; however, reduced glutathione exhibited the opposite behavior. In the presence of CO2, the activity of CIP against E. coli was reduced relative to that under ACs. In conclusion, CO2 interferes with the action of CIP in bacterial cells, generating changes in oxidative stress.

Figures